Literature DB >> 30351302

A large-scale dataset of in vivo pharmacology assay results.

Fiona M I Hunter1, Francis L Atkinson1, A Patrícia Bento1, Nicolas Bosc1, Anna Gaulton1, Anne Hersey1, Andrew R Leach1.   

Abstract

ChEMBL is a large-scale, open-access drug discovery resource containing bioactivity information primarily extracted from scientific literature. A substantial dataset of more than 135,000 in vivo assays has been collated as a key resource of animal models for translational medicine within drug discovery. To improve the utility of the in vivo data, an extensive data curation task has been undertaken that allows the assays to be grouped by animal disease model or phenotypic endpoint. The dataset contains previously unavailable information about compounds or drugs tested in animal models and, in conjunction with assay data on protein targets or cell- or tissue- based systems, allows the investigation of the effects of compounds at differing levels of biological complexity. Equally, it enables researchers to identify compounds that have been investigated for a group of disease-, pharmacology- or toxicity-relevant assays.

Entities:  

Mesh:

Year:  2018        PMID: 30351302      PMCID: PMC6206617          DOI: 10.1038/sdata.2018.230

Source DB:  PubMed          Journal:  Sci Data        ISSN: 2052-4463            Impact factor:   6.444


  13 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

2.  Linking human diseases to animal models using ontology-based phenotype annotation.

Authors:  Nicole L Washington; Melissa A Haendel; Christopher J Mungall; Michael Ashburner; Monte Westerfield; Suzanna E Lewis
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

3.  ChEMBL: a large-scale bioactivity database for drug discovery.

Authors:  Anna Gaulton; Louisa J Bellis; A Patricia Bento; Jon Chambers; Mark Davies; Anne Hersey; Yvonne Light; Shaun McGlinchey; David Michalovich; Bissan Al-Lazikani; John P Overington
Journal:  Nucleic Acids Res       Date:  2011-09-23       Impact factor: 16.971

4.  Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity.

Authors:  Elisa Passini; Oliver J Britton; Hua Rong Lu; Jutta Rohrbacher; An N Hermans; David J Gallacher; Robert J H Greig; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Front Physiol       Date:  2017-09-12       Impact factor: 4.566

5.  Classification and analysis of a large collection of in vivo bioassay descriptions.

Authors:  Magdalena Zwierzyna; John P Overington
Journal:  PLoS Comput Biol       Date:  2017-07-05       Impact factor: 4.475

6.  Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO).

Authors:  Uma D Vempati; Magdalena J Przydzial; Caty Chung; Saminda Abeyruwan; Ahsan Mir; Kunie Sakurai; Ubbo Visser; Vance P Lemmon; Stephan C Schürer
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

7.  PhenoDigm: analyzing curated annotations to associate animal models with human diseases.

Authors:  Damian Smedley; Anika Oellrich; Sebastian Köhler; Barbara Ruef; Monte Westerfield; Peter Robinson; Suzanna Lewis; Christopher Mungall
Journal:  Database (Oxford)       Date:  2013-05-09       Impact factor: 3.451

8.  Evolving BioAssay Ontology (BAO): modularization, integration and applications.

Authors:  Saminda Abeyruwan; Uma D Vempati; Hande Küçük-McGinty; Ubbo Visser; Amar Koleti; Ahsan Mir; Kunie Sakurai; Caty Chung; Joshua A Bittker; Paul A Clemons; Steve Brudz; Anosha Siripala; Arturo J Morales; Martin Romacker; David Twomey; Svetlana Bureeva; Vance Lemmon; Stephan C Schürer
Journal:  J Biomed Semantics       Date:  2014-06-03

9.  The FAIR Guiding Principles for scientific data management and stewardship.

Authors:  Mark D Wilkinson; Michel Dumontier; I Jsbrand Jan Aalbersberg; Gabrielle Appleton; Myles Axton; Arie Baak; Niklas Blomberg; Jan-Willem Boiten; Luiz Bonino da Silva Santos; Philip E Bourne; Jildau Bouwman; Anthony J Brookes; Tim Clark; Mercè Crosas; Ingrid Dillo; Olivier Dumon; Scott Edmunds; Chris T Evelo; Richard Finkers; Alejandra Gonzalez-Beltran; Alasdair J G Gray; Paul Groth; Carole Goble; Jeffrey S Grethe; Jaap Heringa; Peter A C 't Hoen; Rob Hooft; Tobias Kuhn; Ruben Kok; Joost Kok; Scott J Lusher; Maryann E Martone; Albert Mons; Abel L Packer; Bengt Persson; Philippe Rocca-Serra; Marco Roos; Rene van Schaik; Susanna-Assunta Sansone; Erik Schultes; Thierry Sengstag; Ted Slater; George Strawn; Morris A Swertz; Mark Thompson; Johan van der Lei; Erik van Mulligen; Jan Velterop; Andra Waagmeester; Peter Wittenburg; Katherine Wolstencroft; Jun Zhao; Barend Mons
Journal:  Sci Data       Date:  2016-03-15       Impact factor: 6.444

10.  A model-based assay design to reproduce in vivo patterns of acute drug-induced toxicity.

Authors:  Lars Kuepfer; Olivia Clayton; Christoph Thiel; Henrik Cordes; Ramona Nudischer; Lars M Blank; Vanessa Baier; Stephane Heymans; Florian Caiment; Adrian Roth; David A Fluri; Jens M Kelm; José Castell; Nathalie Selevsek; Ralph Schlapbach; Hector Keun; James Hynes; Ugis Sarkans; Hans Gmuender; Ralf Herwig; Steven Niederer; Johannes Schuchhardt; Matthew Segall; Jos Kleinjans
Journal:  Arch Toxicol       Date:  2017-08-29       Impact factor: 5.153

View more
  2 in total

1.  Development of In Silico Methods for Toxicity Prediction in Collaboration Between Academia and the Pharmaceutical Industry.

Authors:  Manuel Pastor; Ferran Sanz; Frank Bringezu
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Evolving applications of the egg: chorioallantoic membrane assay and ex vivo organotypic culture of materials for bone tissue engineering.

Authors:  Karen M Marshall; Janos M Kanczler; Richard Oc Oreffo
Journal:  J Tissue Eng       Date:  2020-10-20       Impact factor: 7.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.